WSHA’s response to ARRIVE trial
March 21, 2018
In February, the abstract from the ARRIVE trial — a multi-center randomized controlled trial comparing induction of labor at 39 weeks gestation with expectant management of labor in first-time mothers —was presented at the annual Society for Maternal-Fetal Medicine (SMFM) conference in Dallas, Texas. ... Read More >>